ClinConnect ClinConnect Logo
Search / Trial NCT06178289

Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skin Damage in Hospitals

Launched by UNIVERSITY GHENT · Dec 11, 2023

Trial Information

Current as of May 30, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Problem statement:

Partial-thickness wounds (erosion/denudation of the epithelial and dermal layers of the skin) can occur due to prolonged exposure of moisture and irritants. Various sources of moisture can cause these superficial wounds called moisture-associated skin damage (MASD) which include wound exudate, bodily fluids from incontinence and effluent from stomas and fistulas. MASD can present as inflammation with or without erosion and even secondary infection. Partial-thickness denudation can be extremely painful and detrimental to the patient. Traditionally a wide array of treatmen...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The patient or their legally authorized representative signed informed consent.
  • The patient is expected to be in the study for the full duration of the trial.
  • The patient has partial thickness wounds caused by moisture (MASD) i.e.,
  • The patient has IAD category 2A or
  • Peri-wound MASD or
  • Peri-stomal MASD.
  • Exclusion Criteria:
  • Patients with a known hypersensitivity or allergy to acrylate or cyanoacrylate.
  • The patient requires topical treatment due to a fungal, bacterial or viral infection in the study area.
  • Intertriginous dermatitis (most often a fungal infection is present).
  • Peri-fistula MASD (would usually require hospitalization).
  • The patient has any other local dermatological disease or skin condition interfering with this study.
  • Patients participating in another study with a known or implied effect on skin barrier function.
  • Patients who are receiving end-of-life care.

About University Ghent

University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.

Locations

Gent, , Belgium

Oudenaarde, , Belgium

Oostende, , Belgium

Patients applied

0 patients applied

Trial Officials

Dimitri Beeckman, PhD

Principal Investigator

University Ghent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported